Log In
    News

    C-Suite Interview with Axcella Therapeutics (AXLA) President & CEO Bill Hinshaw

    11/11/2021
    Health
    0 min read

    Noble Capital Markets Senior Research Analyst Robert LeBoyer interviews Axcella Therapeutics President & CEO Bill Hinshaw.

    Research, News, and Advanced Market Data on AXLA


    View all C-Suite Interviews

    About Axcella Therapeutics

    Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using endogenous metabolic modulator (EMM) compositions. The company’s product candidates are comprised of EMMs and derivatives that are engineered in distinct combinations and ratios to reset multiple biological pathways, improve cellular energetics, and restore homeostasis. Axcella’s pipeline includes lead therapeutic candidates in Phase 2 development for the reduction in risk of overt hepatic encephalopathy (OHE) recurrence, the treatment of Long COVID, and the treatment of non-alcoholic steatohepatitis (NASH). The company’s unique model allows for the evaluation of its EMM compositions through non-IND clinical studies or IND clinical trials. For more information, please visit www.axcellatx.com.

    Share
    Related News
    ‌
    Probe Gold Expands its Monique Gold Deposit with Key Acquisition
    12/20/2024
    Natural Resources

    Probe Gold Expands its Monique Gold Deposit with Key Acquisition

    Probe Gold Inc. has announced the acquisition of the Bermont Claims property, strategically located adjacent to its Monique Gold Deposit in Val-d’Or, Quebec. This move is poised to extend the...
    3 min read
    ‌
    Release – LODE: Comstock Sells Northern Mining Targets to Mackay Precious Metals
    12/20/2024
    Basic Materials

    Release – LODE: Comstock Sells Northern Mining Targets to Mackay Precious Metals

    Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”) today announced it has executed a Membership Interest Purchase Agreement (the “MIPA”) to sell 100% of the northernmost patented and unpatented mining...
    7 min read
    ‌
    Steelcase (SCS) – Reports Third Quarter Results
    12/20/2024
    Industrials

    Steelcase (SCS) – Reports Third Quarter Results

    3Q25 Results. Revenue was $794.9 million, up 2.1% y-o-y, with higher revenue from government, large corporate, healthcare, and education customers as the drivers. Organic revenue was up 3%, with Americas up...
    2 min read
    ‌
    Great Lakes Dredge & Dock (GLDD) – $182 Million of Awarded Work
    12/20/2024
    Industrials

    Great Lakes Dredge & Dock (GLDD) – $182 Million of Awarded Work

    Awarded Work. Great Lakes announced an additional $182 million of awarded work across four projects. The new projects were part of the $465 million of low bids and options pending as...
    3 min read

    Inbox Intel from Channelchek.

    Informed investors make more money. And it’s all about timing. Get it when it happens.

    By clicking submit you are agreeing to the Terms of Use and Privacy Policy
    Log In